CONMED Receivables 2010-2024 | CNMD

CONMED receivables from 2010 to 2024. Receivables can be defined as the total amount of collectibles for a company
CONMED Annual Receivables
(Millions of US $)
2023 $242
2022 $191
2021 $184
2020 $177
2019 $189
2018 $182
2017 $167
2016 $148
2015 $134
2014 $130
2013 $144
2012 $142
2011 $136
2010 $145
2009 $126
CONMED Quarterly Receivables
(Millions of US $)
2024-06-30 $239
2024-03-31 $241
2023-12-31 $242
2023-09-30 $230
2023-06-30 $229
2023-03-31 $213
2022-12-31 $191
2022-09-30 $197
2022-06-30 $202
2022-03-31 $183
2021-12-31 $184
2021-09-30 $165
2021-06-30 $169
2021-03-31 $164
2020-12-31 $177
2020-09-30 $167
2020-06-30 $143
2020-03-31 $167
2019-12-31 $189
2019-09-30 $173
2019-06-30 $179
2019-03-31 $172
2018-12-31 $182
2018-09-30 $161
2018-06-30 $162
2018-03-31 $158
2017-12-31 $167
2017-09-30 $147
2017-06-30 $145
2017-03-31 $140
2016-12-31 $148
2016-09-30 $133
2016-06-30 $140
2016-03-31 $134
2015-12-31 $134
2015-09-30 $125
2015-06-30 $130
2015-03-31 $129
2014-12-31 $130
2014-09-30 $128
2014-06-30 $140
2014-03-31 $132
2013-12-31 $144
2013-09-30 $134
2013-06-30 $143
2013-03-31 $138
2012-12-31 $142
2012-09-30 $134
2012-06-30 $136
2012-03-31 $142
2011-12-31 $136
2011-09-30 $131
2011-06-30 $153
2011-03-31 $147
2010-12-31 $145
2010-09-30 $141
2010-06-30 $143
2010-03-31 $149
2009-12-31 $126
2009-09-30 $110
2009-06-30 $94
2009-03-31 $91
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $2.312B $1.245B
CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.143B 21.32
Becton Dickinson (BDX) United States $67.812B 17.83
Cardinal Health (CAH) United States $29.438B 15.96
West Pharmaceutical Services (WST) United States $23.723B 48.46
Cooper (COO) United States $20.623B 29.35
Labcorp (LH) United States $20.401B 16.92
Align Technology (ALGN) United States $16.815B 32.18
Henry Schein (HSIC) United States $8.514B 16.22
Merit Medical Systems (MMSI) United States $6.067B 30.98
DENTSPLY SIRONA (XRAY) United States $3.508B 9.54
Patterson (PDCO) United States $1.855B 9.79
STAAR Surgical (STAA) United States $1.499B 55.31
Lifevantage (LFVN) United States $0.176B 23.40
Pro-Dex (PDEX) United States $0.154B 30.74